Inhibition of cardiovascular metabolic and hemodynamic effects of adenosine by aminophylline.
D000628:Aminophylline / Q000494:pharmacology*; D000818:Animals; D001783:Blood Flow Velocity; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D004395:Dye Dilution Technique; D006321:Heart / Q000187:drug effects; D006334:Heart Function Tests; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism*; D009705:Nucleosides / Q000037:antagonists & inhibitors*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D014665:Vasodilator Agents / Q000037:antagonists & inhibitors*
D009705:Nucleosides; D014665:Vasodilator Agents; D000628:Aminophylline; D010100:Oxygen